The licence agreement bolsters Kite’s expertise in synthetic biology for oncology More: Kite and Refuge Biotechnologies to work together to research blood cancer Source: News
read moreScynexis plans to cut 40% of staff and license its approved antifungal in pivot to R&D fkansteiner Thu, 10/20/2022 – 15:54 More: Scynexis plans to cut 40% of staff and license its approved antifungal in pivot to R&D Source: fierce
read moreJ&J and Corning put more than 100 New York jobs on the chopping block in latest pharma layoff round fkansteiner Thu, 10/20/2022 – 10:33 More: J&J and Corning put more than 100 New York jobs on the chopping block in
read moreAlembic hit with Form 483, citing 4 observations at Panelav plant in India zbecker Thu, 10/20/2022 – 10:25 More: Alembic hit with Form 483, citing 4 observations at Panelav plant in India Source: fierce
read moreCDC and Fox News pundit Carlson spar in Twitter tangle over COVID vaccine recommendation for kids kdunleavy Thu, 10/20/2022 – 10:24 More: CDC and Fox News pundit Carlson spar in Twitter tangle over COVID vaccine recommendation for kids Source: fierce
read moreJ&J, Legend’s Carvykti delivers encouraging early growth ahead of key myeloma readout aliu Thu, 10/20/2022 – 10:00 More: J&J, Legend's Carvykti delivers encouraging early growth ahead of key myeloma readout Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals